In Vivo Infographics
Does It Grow On Trees? 2018 VC Financing Trends
Last year saw some serious early-stage funding, major later stage financings and more cash filtering into seed rounds. Follow the timeline of venture capital transactions throughout 2018 worth more than $100m. A record-breaking year for biotech financing.
Building A Biotech: Industry Veteran Moroney Reflects
Simon Moroney has led the German antibody technology biotech MorphoSys since 1992. Having taken the decision to retire just as the firm is entering the next phase in its evolution, he explains to In Vivo why the time is right.
One Rare Disease Drug’s Access Journey Across The Globe
Infographic: Vertex, the first company to produce a drug to treat the underlying cause of cystic fibrosis, has fought for fair (and high) prices for its medicines to reflect their value as treatments for the cause of a genetic disease. The company has sought innovative reimbursement agreements for its CF products in various countries.
Drug Delivery Trends Across The Biopharma Pipeline
Exploring route of administration, mode of action, clinical trial, and therapy area trends across the biopharma pipeline.
Infographic – 2018 Pharma Pipeline Snapshot
Infographic examines the current status of biopharma pipelines by trial phase, company, and therapeutic areas.
Digital Health - An Infographic
The world of health care has become much connected thanks to the venture capital that has already poured into health-related social media structures and the Internet-Of-Things. People are connected to sensors, devices are connected to phones, and patients are connected to physicians. The latecomers – pharmaceutical and medtech firms – can now plug in to this partly-formed network both through direct investment and their strategic venture funds.
Infographic: Human Capital In Biopharma
A sampling of data from In Vivo and the EBD Academy's comprehensive survey, Future-Proofing Human Capital In Global Life Sciences.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.